Close

Maxim Group Starts Quoin Pharmaceuticals (QNRX) at Buy

January 7, 2022 7:53 AM EST
Get Alerts QNRX Hot Sheet
Price: $1.56 +2.63%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 21 | New: 16
Join SI Premium – FREE

Maxim Group analyst Naz Rahman initiates coverage on Quoin Pharmaceuticals (NASDAQ: QNRX) with a Buy rating and a price target of $5.00.


For an analyst ratings summary and ratings history on Quoin Pharmaceuticals click here. For more ratings news on Quoin Pharmaceuticals click here.


Shares of Quoin Pharmaceuticals closed at $1.74 yesterday.


You May Also Be Interested In





Related Categories

New Coverage